Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution

Brinda Balakrishnan, John F. Dooley, Gregory A. Kopia, Elazer R. EdelmanJournal of Controlled Release 2007 · DOI

TL;DR

This paper uses computational modeling to investigate how the release rate of drugs from stents affects their deposition, retention, and distribution within the arterial wall. The key finding is that optimal arterial drug uptake, and thus potential therapeutic effect, occurs when the drug release rate matches the arterial absorption rate, suggesting that precise control over drug release kinetics is crucial for maximizing the efficacy and minimizing the toxicity of drug-eluting stents.

What Problem Does This Paper Address?

Drug-eluting stents (DES) are widely used to prevent restenosis (re-narrowing of arteries) after angioplasty. The effectiveness of these stents hinges on delivering anti-proliferative drugs directly to the arterial wall. However, the precise relationship between how quickly a drug is released from the stent, how much of it actually reaches and stays in the arterial tissue, and how this translates to a therapeutic benefit has remained unclear. This paper aims to bridge this gap by exploring how variations in drug release kinetics and administered dose influence arterial drug deposition, retention, and distribution, which are critical determinants of the drug's biological outcome.

Methods

The authors employed a computational modeling approach using a 2-dimensional transient finite volume model. This model simulated drug transport from a drug-laden stent strut into the surrounding arterial wall, considering both diffusion and convection (washout by blood flow). Key aspects of the model include:

  • Fluid Dynamics: A steady-state Navier-Stokes equation was used to model blood flow, assuming Newtonian fluid behavior. This was a simplification to manage computational complexity, as pulsatile flow would have significantly increased computational demands.
  • Drug Transport: The model incorporated transient diffusion and convection for drug transport within the blood and arterial tissue, and primarily diffusion for drug release from the stent coating.
  • Parameter Variation: The model allowed for systematic variation of parameters such as drug diffusivity within the coating, coating thickness, drug concentration, and drug load.
  • Validation: The model's predictions for drug release kinetics were validated against experimental data from porcine coronary arteries implanted with sirolimus-eluting stents.

Datasets

The study did not introduce new datasets. Instead, it utilized:

  • Empirical data: In vivo data from porcine coronary arteries implanted with sirolimus-eluting stents were used to validate the computational model's predictions of drug release kinetics.
  • Literature-based parameters: Fluid mechanical properties of blood and drug transport parameters in arterial tissue were based on existing literature.

Key Insights and Ideas

  • Release Rate is King: The rate at which a drug is released from the stent is a more critical determinant of arterial drug uptake than the total amount of drug initially present.
  • The "Sweet Spot" for Uptake: Optimal arterial drug uptake occurs when the drug release rate is matched to the arterial tissue's absorption capacity. Too fast a release leads to dilution and washout, while too slow a release limits the amount of drug presented to the tissue.
  • Concentration vs. Duration: Modulating the drug concentration in the coating has a potent impact on the magnitude of arterial drug deposition, whereas changes in the coating's drug mass primarily affect the duration of release.
  • Bolus Release is Inefficient: Releasing the drug in a rapid bolus is predicted to result in minimal arterial drug deposition and retention, as the drug is quickly diluted and cleared.
  • Continuous Release is Suboptimal: While month-long drug release provides sustained drug levels, the slow presentation rate can limit overall arterial uptake.
  • Strut Dimensions Matter (but less than release rate): While strut dimensions and their contact area with the arterial wall can influence drug deposition, their impact is less significant than the drug release kinetics.

Key Results

  • Model Validation: The computational model accurately predicted in vivo fractional drug release from stent coatings, with a root mean squared error of less than 0.1.
  • Release Kinetics and Uptake:
    • Bolus release (seconds): Led to low, transient arterial drug uptake.
  • Hour-long release: Maximized arterial drug uptake by matching release and absorption rates.
  • Month-long release: Resulted in submaximal but more efficient uptake, with longer retention.
  • Drug Concentration Impact: A 3-fold increase in stent drug concentration led to a commensurate 3-fold elevation in arterial drug uptake.
  • Drug Mass Impact: Increasing drug load via thicker coatings resulted in slower release but prolonged drug levels, leading to a modest increase (10-20%) in peak arterial drug deposition.

Limitations and Future Work

  • Steady Flow Assumption: The model used steady-state blood flow, which simplifies the complex pulsatile nature of blood flow in arteries. Future work could employ modified computational approaches to incorporate flow pulsatility.
  • Simplified Drug Transport: The model primarily considered diffusive drug transport within the arterial wall, neglecting other potential mechanisms like pressure-driven radial flow and drug binding to arterial components.
  • Absence of Dose Response: The study notes that despite variations in drug uptake, clinical trials often fail to demonstrate a clear dose-response relationship. This suggests that the arterial wall might regulate its response, or that the therapeutic window is narrow, leading to a threshold or binary biologic response.
  • Future Directions: The authors suggest further work to fully characterize the arterial wall's role in drug metabolism and response, and to explore the interplay between arterial drug dose, exposure time, absorption capacity, and the extent of arterial injury in determining therapeutic outcomes. They also propose investigating the aggregate impact of additional physical phenomena on arterial drug uptake.

Summary updated

BibTeX
@article{balakrishnan2007intravascular,
  author = {Brinda Balakrishnan and John F. Dooley and Gregory A. Kopia and Elazer R. Edelman},
  title = {{Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution}},
  journal = {Journal of Controlled Release},
  year = {2007},
  doi = {10.1016/j.jconrel.2007.06.025},
}
Figure